Literature DB >> 23043253

Altered BCR and CD40 signalling are associated with clinical outcome in small lymphocytic lymphoma/chronic lymphocytic leukaemia and marginal zone lymphoma patients.

Egil S Blix, Jonathan M Irish, Anne Husebekk, Jan Delabie, Anne M Tierens, June H Myklebust, Arne Kolstad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23043253      PMCID： PMC3767388          DOI： 10.1111/bjh.12073

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cells.

Authors:  E Gross; F-E L'Faqihi-Olive; L Ysebaert; M Brassac; S Struski; S Kheirallah; J-J Fournié; G Laurent; A Quillet-Mary
Journal:  Leukemia       Date:  2010-09-09       Impact factor: 11.528

2.  Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells.

Authors:  K Kato; M J Cantwell; S Sharma; T J Kipps
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

3.  B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression.

Authors:  Jonathan M Irish; June H Myklebust; Ash A Alizadeh; Roch Houot; Jeff P Sharman; Debra K Czerwinski; Garry P Nolan; Ronald Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-11       Impact factor: 11.205

4.  Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection.

Authors:  Alexandra Traverse-Glehen; Frédéric Davi; Elsa Ben Simon; Evelyne Callet-Bauchu; Pascale Felman; Lucile Baseggio; Sophie Gazzo; Catherine Thieblemont; Carole Charlot; Bertrand Coiffier; Françoise Berger; Gilles Salles
Journal:  Haematologica       Date:  2005-04       Impact factor: 9.941

5.  A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154.

Authors:  W G Wierda; J E Castro; R Aguillon; D Sampath; A Jalayer; J McMannis; C E Prussak; M Keating; T J Kipps
Journal:  Leukemia       Date:  2010-09-30       Impact factor: 11.528

6.  Increased trisomy 12 frequency and a biased IgVH 3-21 gene usage characterize small lymphocytic lymphoma.

Authors:  Agnès Daudignon; Stéphanie Poulain; Pierre Morel; Dominique Penther; Françoise Parmentier; Brigitte Bouchindhomme; José Fernandes; Patrick Duthilleul; Christian Bastard
Journal:  Leuk Res       Date:  2009-12-02       Impact factor: 3.156

Review 7.  Chronic lymphocytic leukaemia.

Authors:  G Dighiero; T J Hamblin
Journal:  Lancet       Date:  2008-03-22       Impact factor: 79.321

8.  Spontaneous regression of chronic lymphocytic leukemia: clinical and biologic features of 9 cases.

Authors:  Ilaria Del Giudice; Sabina Chiaretti; Simona Tavolaro; Maria Stefania De Propris; Roberta Maggio; Francesca Mancini; Nadia Peragine; Simona Santangelo; Marilisa Marinelli; Francesca Romana Mauro; Anna Guarini; Robin Foà
Journal:  Blood       Date:  2009-04-22       Impact factor: 22.113

9.  BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells.

Authors:  Anna Guarini; Sabina Chiaretti; Simona Tavolaro; Roberta Maggio; Nadia Peragine; Franca Citarella; Maria Rosaria Ricciardi; Simona Santangelo; Marilisa Marinelli; Maria Stefania De Propris; Monica Messina; Francesca Romana Mauro; Ilaria Del Giudice; Robert Foà
Journal:  Blood       Date:  2008-05-16       Impact factor: 22.113

10.  Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.

Authors:  Stuart Lanham; Terry Hamblin; David Oscier; Rachel Ibbotson; Freda Stevenson; Graham Packham
Journal:  Blood       Date:  2002-09-26       Impact factor: 22.113
  10 in total
  2 in total

1.  Human Germinal Center B Cells Differ from Naïve and Memory B Cells in CD40 Expression and CD40L-Induced Signaling Response.

Authors:  Kanutte Huse; Cara E Wogsland; Hannah G Polikowsky; Kirsten E Diggins; Erlend B Smeland; June H Myklebust; Jonathan M Irish
Journal:  Cytometry A       Date:  2019-03-05       Impact factor: 4.355

2.  Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.

Authors:  June H Myklebust; Joshua Brody; Holbrook E Kohrt; Arne Kolstad; Debra K Czerwinski; Sébastien Wälchli; Michael R Green; Gunhild Trøen; Knut Liestøl; Klaus Beiske; Roch Houot; Jan Delabie; Ash A Alizadeh; Jonathan M Irish; Ronald Levy
Journal:  Blood       Date:  2016-12-23       Impact factor: 22.113
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.